WishBone and SpineGuard Sign National Distribution Agreement for U.S. Pediatric Orthopedic Centers

0

Enter Wall Street with Street Insider Premium. Claim your 1-week free trial here.


New partnership to expand access for pediatric orthopedic surgeons performing spine surgery

WARSAW, Ind. & BOULDER, Colorado & PARIS – (BUSINESS WIRE) – Regulatory news:

WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, and SpineGuard (FR0011464452 – ALSGD), an innovative company deploying its dynamic surgical guidance detection (DSG) technology to secure and streamline bone implant placement announced today long-term partnership with, for the exclusive distribution rights of the PediGuard® intelligent spinal drilling devices to children’s hospitals across the United States.

“This strategic alignment with SpineGuard enables WishBone’s spine division to support and focus 100% on the pediatric spine community. Our goal is to provide clinical solutions to the unmet needs of surgeons related to improving patient safety and improving practice outcomes, ”said Jeff Wertz, Executive Vice President of Spine, WishBone Medical . “Increasing accuracy rates when performing a pilot hole in axially rotating spines during scoliosis surgery is essential for a successful outcome. Additionally, surgical teams can dramatically reduce the amount of radiation exposure in children associated with preoperative CT scans and intraoperative x-rays taken during surgery, a significant risk factor that can be significantly reduced and minimized in AIS procedures.

“We will implement this very promising collaboration in close cooperation to integrate with our existing network of US agents, taking advantage of the new DSG Connect platform which adds visual display and data logging capabilities. Despite the evolution of today’s spine surgery solutions, the design logic inherent in the DSG continues to elevate the key elements that have kept DSG technology extremely relevant in this risk mitigation, low exposure. radiation, minimal setup, and a 12-year clinical history of providing true -time accuracy that rivals all other much more expensive modalities, ”said Patrick Pilcher, vice president of sales and marketing, SpineGuard America. North.

Pierre Jérôme, CEO and Co-Founder of SpineGuard, adds: “We are delighted to partner with WishBone to bring our X-ray-free real-time guidance technology to more US surgeons and hospitals providing pediatric orthopedic care. and help them make spine surgery safer. This congruent alliance will significantly expand our trade footprint in the United States. WishBone has the passion, leadership and access to drive faster and wider adoption of our DSG technology in spinal deformity correction, a historical foundation that is an integral part of SpineGuard.

“Thanks to the contracts WishBone has with several group purchasing organizations, we are now networked with 242 of the 268 independent children’s hospitals performing orthopedic surgery,” said Nick Deeter, Founder, President and CEO of WishBone Medical. “This level of access will provide surgeons with the ability to immediately use the DSG and minimize radiation exposure for their patients. This technology is a perfect complement to WishBone’s sterile spine solutions as we strive to raise surgical standards for children.

The safety and efficacy of using DSG for spine surgery has been proven by over 85,000 surgeries worldwide and backed by 17 peer-reviewed scientific publications. * DSG probes provide sensation haptic and tactile, act as an internal GPS system inside the pedicle, and improve the ability of residents and fellows to place spinal implants more precisely for increased patient safety.1 Literature supports accuracy rates DSGs equal or superior to navigation / robotic alternatives, without the inconvenience of disrupting surgical workflow and avoiding CT scans. The combination of DSG technology with the ASTRA Spine Deformation System will provide a clinical solution to help meet the growing needs of the pediatric spine surgeon community.

* A complete list of supporting publications is available on the manufacturer’s website: https://www.spineguard.com/dynamic-surgical-guidance-technology

1. Williams, John and Samdani, Amer and Defino, Helton and George, Keri and Gaughan, John and Betz, Randal. (2014). Anticipation of the breach of the vertebral pedicle by dynamic surgical guidance. Coluna / Columna. 13. 210-213. 10.1590 / S1808-18512014130300R85.

About SpineGuard®

Founded in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative company deploying its proprietary real-time detection technology without DSG® radiation (Dynamic Surgical Guidance) to secure and rationalize the placement of implants in the skeleton . SpineGuard designs, develops and markets medical devices that have been used in more than 85,000 surgical procedures worldwide. Seventeen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits offered by DSG® to patients, surgeons, surgical staff and hospitals. On the strength of these solid fundamentals and several strategic partnerships, SpineGuard has extended its technological platform with a breakthrough innovation: the “intelligent” pedicle screw launched at the end of 2017 and broadens the field of applications in dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, MD, Ph.D., and Alain Vanquaethem, biomedical engineer. SpineGuard is engaged in several ESG initiatives. For more information, visit www.spineguard.com

Warning

SpineGuard securities may not be offered or sold in the United States because they have not been and will not be registered under the Securities Act or any securities law of the United States, and SpineGuard has not intends to make a public offering of its securities in the United States. This is an announcement and not a prospectus, and the information contained in this document does not constitute and does not constitute an offer to sell or the solicitation of an offer to buy, and there will be no nor any sale of the securities referred to herein in the United States in which such an offer, solicitation or sale would be unlawful prior to registration or exemption from registration.

About WishBone Medical

WishBone Medical is a global pediatric orthopedics company committed to providing anatomically appropriate implants and instruments in sterile, single-use intervention kits designed to prevent infections, reduce overall costs to clients, and achieve the best results. better outcomes for children around the world. The WishBone Medical family of companies offers a comprehensive product line of “head to toe” innovative systems with operations in Warsaw, IN; Istanbul and Singapore. For more information, visit www.WishBoneMedical.com or contact Kaitlyn Hughes, Director of Marketing and Communications, at + 1-574-306-4006.

SpineGuard

Pierre Jerome

CEO & President

Phone: +33 1 45 18 45 19

[email protected]

NewCap

Investor Relations & Financial Communication

Mathilde Bohin / Pierre Laurent

Phone: +33 1 44 71 94 94

[email protected]

Kaitlyn hughes

Phone. : + 1-574-306-4006

[email protected]

www.WishBoneMedical.com

Source: SpineGuard


Source link

Share.

Comments are closed.